| Cas No.: | 875787-07-8 |
| 名称: | 2H-Indazole, 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)- |
| 别名: | LXR-623, LXR 623 |
| SMILES: | N1=C2C(C=CC=C2C(F)(F)F)=C(C2=CC=C(F)C=C2)N1CC1=CC=C(F)C=C1Cl |
| 分子式: | C21H12ClF5N2 |
| 分子量: | 422.77 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | LXR-623, a novel Liver X Receptor modulator, displays neutral lipid effects in Cholesteryl Ester Transfer Protein-expressing species and inhibits atherosclerotic lesion progression in Low Density Lipoprotein receptor knockout mice For the detailed information about the solubility of LXR623 in water, the solubility of LXR623 in DMSO, the solubility of LXR623 in PBS buffer, the animal experiment（test） of LXR623 ,the in vivo,in vitro and clinical trial test of LXR623 ,the cell experiment（test） of LXR623 ,the IC50, EC50 and Affinity of LXR623 , please contact DC Chemicals. |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
